• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Selective Proteasome Inhibito

  2026-05-27

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) is a potent, reversible, and cell-permeable proteasome inhibitor that targets the chymotryptic activity of the 26S proteasome. This compound induces cell cycle arrest and apoptosis, providing a valuable tool for apoptosis research and proteasome inhibition assays. Its efficacy and selectivity are demonstrated in multiple in vitro and in vivo models, with well-defined solubility and storage parameters.

• Multiomics Reveals Crossbreeding Effects on Xingguo Goose Me

  2026-05-26

  This study integrates transcriptomic and metabolomic analysis to dissect how crossbreeding and sex influence growth and meat quality in Xingguo gray geese. The findings clarify molecular pathways underpinning improved production traits in ternary hybrids, offering new targets for genetic selection and practical breeding strategies.

• Caspase-8 Fluorometric Assay Kit for Advanced Apoptosis Assa

  2026-05-26

  Unlock precise detection of IETD-dependent caspase activity with the Caspase-8 Fluorometric Assay Kit. This guide translates recent breakthroughs and expert workflows into actionable strategies for robust apoptosis, drug screening, and neurodegenerative disease research.

• Mechanistic Insights into Diuron-Induced Acute Renal Injury

  2026-05-25

  This study provides the first integrated mechanistic analysis of Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) nephrotoxicity, combining network toxicology, transcriptomics, and cell-based assays. The findings reveal JAK2/STAT1 pathway activation as a major driver of Diuron-induced acute kidney injury, offering a foundation for future environmental risk assessment and laboratory toxicology workflows.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Axis Modul

  2026-05-25

  The reference study reveals that gramine, a natural indole alkaloid, selectively inhibits triple-negative breast cancer (TNBC) by inducing ferroptosis through disruption of the CUL3–MTDH ubiquitination pathway. These findings elucidate a novel regulatory axis in ferroptosis and support gramine's potential as a promising candidate for targeted TNBC therapy.

• LNP Structure and Administration Route Shape mRNA Delivery i

  2026-05-24

  This study demonstrates that both the composition of lipid nanoparticles (LNPs) and their route of administration critically govern mRNA delivery efficacy, immunogenicity, and safety in pregnant mice. The findings provide mechanistic guidance for designing RNA therapeutics during pregnancy, with implications for minimizing maternal immune activation and fetal risk.

• Redefining mRNA Isolation: Strategic Leverage for Translatio

  2026-05-23

  This thought-leadership article explores how advanced superparamagnetic Oligo (dT) 25 Beads enable robust, high-fidelity mRNA isolation critical for translational research in neurodegeneration and immunosenescence. Integrating mechanistic insight, competitive benchmarking, and evidence from recent Alzheimer’s disease studies, we provide actionable guidance for researchers aiming to bridge bench to bedside with superior molecular tools.

• Ceftolozane/Tazobactam: Advancing Therapy Against Resistant

  2026-05-22

  The referenced study investigates the clinical and mechanistic profile of ceftolozane/tazobactam, a novel cephalosporin/beta-lactamase inhibitor with enhanced activity against multidrug-resistant gram-negative bacteria, notably Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its pharmacokinetic and pharmacodynamic advantages inform future antibacterial research, especially in the context of evolving resistance.

• Oligo (dT) 25 Beads: Technical Guide for mRNA Isolation Work

  2026-05-22

  Oligo (dT) 25 Beads enable efficient capture and purification of eukaryotic mRNA via polyA tail hybridization. They are best suited for workflows requiring high-integrity mRNA for downstream molecular biology applications. These beads are not recommended for prokaryotic RNA or workflows lacking polyadenylated targets.

• Afatinib (BIBW 2992): Powering Advanced Cancer Assembloid Mo

  2026-05-21

  Afatinib's irreversible inhibition of the ErbB receptor family is transforming cancer biology research, enabling precise modeling of drug resistance within complex tumor microenvironments. Leverage its robust performance in assembloid workflows to optimize targeted therapy studies and dissect cellular interactions underpinning treatment response.

• Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research

  2026-05-21

  Rotigotine stands out as a powerful dopamine D2/D3 receptor agonist, enabling advanced modeling of Parkinson’s disease and dopaminergic signaling in both cellular and animal systems. This article delivers stepwise workflows, troubleshooting strategies, and actionable insights, spotlighting the translational leap enabled by nose-to-brain delivery and nanoparticle formulations.

• Oligo (dT) 25 Beads: Practical Guide for Eukaryotic mRNA Iso

  2026-05-20

  Oligo (dT) 25 Beads provide a reliable solution for isolating polyadenylated mRNA from complex eukaryotic samples. This product is best suited for workflows requiring high-integrity mRNA for molecular assays such as RT-PCR and next-generation sequencing. It is not intended for nucleic acid purification outside the scope of polyA-tailed mRNA capture or for use with prokaryotic RNA.

• PP 2 (AG 1879) for Src Kinase Pathway Inhibition in Cell Mod

  2026-05-20

  PP 2 (AG 1879) empowers researchers to dissect Src-mediated signaling with nanomolar precision, enabling robust investigation of cancer biology, immune cell function, and cytoskeletal dynamics. This guide delivers actionable workflows, key troubleshooting, and insight from cutting-edge literature to maximize experimental success with this selective Src kinase inhibitor.

• Oligo (dT) 25 Beads: Advancing mRNA Capture for Translationa

  2026-05-19

  This thought-leadership article explores how Oligo (dT) 25 Beads, leveraging magnetic bead-based mRNA purification, are revolutionizing eukaryotic mRNA isolation. By synthesizing mechanistic insights, experimental rigor, and translational opportunity—anchored by cutting-edge cancer transcriptomics research—the piece offers strategic guidance for researchers aiming to bridge discovery with clinical relevance. Integrating current literature, best-practice protocol parameters, and a competitive landscape analysis, the article highlights new frontiers unlocked by APExBIO’s Oligo (dT) 25 Beads, moving beyond typical product narratives into the realm of precision, reproducibility, and actionable data.

• Z-VAD-FMK in Apoptosis Inhibition: Protocols and Pitfalls

  2026-05-19

  Z-VAD-FMK is the gold-standard pan-caspase inhibitor for dissecting apoptosis and cell death pathways in both basic and translational models. This article delivers actionable workflows, troubleshooting strategies, and key innovations from leading research, empowering robust apoptosis inhibition and mechanistic insight.

14402 records 6/961 page Previous Next First page 上5页 678910 下5页 Last page